|

Doctors Still Waiting to Test Buprenorphine’s Promise

Join Together Online
January 21, 2003

While 616 physicians nationwide are now authorized to prescribe buprenorphine, its widespread use is still an issue, the Baltimore Sun reported on January 15.

Product availability is the first problem. Despite receiving FDA approval in October, the manufacturer did not ship the product to pharmaceutical warehouses until last week.

A more important issue is low interest among primary care physicians. Physicians who do treat addiction say lack of training, concern about having an “unsavory clientele,” and “taking on a complicated sideline that doesn’t pay well” may be reasons why some primary care physicians are not interested.

Without them, there is little chance of treating opiate addiction as a chronic illness. “We need to treat this much more as a health condition and bring this to the general medical world, decreasing the stigma,” said Dr. Peter L. Beilenson, Baltimore health commissioner. But others are confident that the drug will see widespread use once news of its promise spreads.

A third barrier is a federal rule that limits physicians who prescribe buprenorphine to 30 buprenorphine patients per practice. The rule was designed to prevent buprenorphine “mills,” but has stymied institutions such as Johns Hopkins School of Medicine, which is legally considered a single practice.

Dr. Eric Strain, whose research at Johns Hopkins helped get buprenorphine approved, said he doesn’t even know if he will get his license. When asked to certify on his application that he would abide by the 30-patient rule, he refused.

“I wrote in the box that I cannot certify this,” Strain said. “I’m curious to see what happens.”

Similar Posts

  • TEXNAMA

    Admin 08/25/2021

    Texas Alliance of Methadone Advocates We are dedicated to educating all methadone patients, counselors, familes, employers about the benefits of methadone. We are volunteers made up of patients, ex-patients, family members, employers, counselors, providers, doctors and you. We want to end the stigma associated with being on Methadone Maintence Treatment (MMT) by educating both patients…

  • The President’s Office

    Admin 08/17/2022

    Methadone treatment is entering a new era giving methadone patients opportunities that they never had before. Our views and issues are being taken seriously by many and it is important that advocacy organizations continue their important role as the patient’s voice. It is because of the hard work of many of the NAMA chapters that…

  • |

    What Is NAMA Recovery?

    Admin 03/14/2023

    The National Alliance for Medication Assisted Recovery (NAMA-R) is an organization of medication assisted treatment (MAT) patients, healthcare professionals, friends, and associates working together for greater public understanding and acceptance of MAT. Promotingquality MAT as the most effective modality for the treatment of opiate dependence. NAMA-R’s Goals To eliminate discrimination toward MAT patients To create…

  • Syringe Patrol

    Admin 11/22/2021

    Starting Patrol Heading for the bicycle Tom Jensen starts on his daily patrol to search out used syringes left on the streets last night. First Check The yellow jacket marked “Sprøjte Patruljen” lets the community know that they are safe and BF is on the job picking up used syringes and other paraphernalia. A Syringe…

  • NOTE:

    Admin 08/18/2022

    The Federal Regulations Pages are a work in progress. In coming weeks they will be better formatted, indexed, etc. But due to overwhelming demand, we have decided to place them up AS IS for the time being. Please inform us of typos, etc. PS- New York State regulations coming soon! If you have the methadone…